IP Library Granted Patent US 8,361,389
Granted Patent B2
US 8,361,389 · App. 13/302,020 · Granted Jan 29, 2013

Monitoring methods and apparatus

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,361,389
App. No.
13/302,020
Granted
Jan 29, 2013
Kind
B2
Abstract

A device for remote management of patients suffering from heart failure and hypertension can measure one or more biomarker. The device aids in monitoring the efficacy and safety of treatment in such patients.

Claims (16)

1. A device for testing and recording the levels of one or more biomarkers that provide information about a patient's health, the device comprising:

a testing cartridge configured to measure, in a sample taken from a patient, a level of a brain natriuretic peptide (BNP), and a level of a marker of renal function;

a memory capable of storing the results of the measurement of the level of BNP and the marker of renal function;

a detector for providing a test result of the measured BNP and marker of renal function;

a display for presenting information to the patient;

an input region to enable a patient to input data in response to information presented on the display; and

a communication port configured to communicate the measured level of BNP, the measured level of the marker of renal function, data input by the patient, or a combination thereof, to a health care provider,

wherein the device can be configured to provide instructions to the patient to seek medical care if the levels of at least one of the measured BNP and marker of renal function exceeds a predetermined threshold or if the patient indicates that acute symptoms are present; and

wherein the device is personalized for the patient based on age, gender, body mass or disease status of the patient.

2. The device of claim 1 , wherein the marker of renal function includes creatinine or Cystatin C.

3. The device of claim 1 , wherein the BNP includes active BNP and an inactive BNP (N-BNP).

4. The device of claim 1 , wherein the device is configured to compare the result of a measurement of the level of BNP to a stored result.

5. The device of claim 4 , wherein the memory is further capable of storing a threshold value of the level of the BNP.

6. The device of claim 5 , wherein the device is configured to compare the result of a measurement of the level of the BNP to the threshold value.

7. The device of claim 6 , wherein the device is configured to instruct the patient to alter a treatment plan when the level of the BNP exceeds the threshold value.

8. The device of claim 6 , wherein the communication port is further configured to receive information from the health care provider.

Assignments (1)
CONFIRMATORY ASSIGNMENT Recorded Oct 30, 2020
From: ALERE SWITZERLAND GMBH
To: ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY
Reel/Frame 054260/0479 →